๐ฐ Delivery Technologies News
Delivery Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Delivery Technologies. Real-time updates on events, politics, business and more.
May 5, 2024
Yesterday (April 29), Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its AI-enabled Route Scouting Service (RSS).
May 5, 2024
Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine, has announced a funding to the tune of $6.5 million.
April 30, 2024
Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine, has announced a funding to the tune of $6.5 million.
April 30, 2024
Yesterday (April 29), Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its AI-enabled Route Scouting Service (RSS).
April 25, 2024
Wuxi AppTec says recent allegations made by the US government that it has shared clients' data with Beijing without consent are โmisleadingโ and โinaccurateโ.
April 11, 2024
Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and semi-solids products.
April 4, 2024
Pluss, a leading provider of temperature-controlled packaging solutions, today (April 3) launched its latest innovation, the Celsure XL VIP pallets.
April 2, 2024
OSP was lucky enough to talk to David Menzies (pictured), executive director, technology solutions at ICON to find out how he thinks the pharma industry needs to overcome the real-world data challenges.
March 28, 2024
Being patient focused is becoming a cliche and actions speak louder than words Anju's Larry Birch claimed during SCOPE 2024.
March 27, 2024
In order to find out, OSP sat down with Brigham Hyde to ask him a number of questions about the company's technology and what it is doing to upgrade traditional trial methods.